{"meta":{"query_hash":"f2f3bbffdd32","filters":{"venue":"Hematology/Oncology and Stem Cell Therapy"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f2f3bbffdd32","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hematology%2FOncology+and+Stem+Cell+Therapy"},"results":[{"id":"W1987621661","doi":"10.1016/s1658-3876(09)50041-6","title":"The National Oncology Program","year":2009,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; London Health Sciences Centre","funders":"","keywords":"General partnership; Medicine; Oncology; Family medicine; Internal medicine; Medical physics; Political science","score_opus":0.017639780555448015,"score_gpt":0.30884220615980107,"score_spread":0.29120242560435305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987621661","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066050105,0.0059017655,0.0015930368,0.095897876,0.0054837125,0.0019784772,0.018603396,0.0010876141,0.8628491],"genre_scores_gemma":[0.031179368,0.008661643,0.004035547,0.029552888,0.0016371063,0.0016635254,0.020470954,0.00025914444,0.90253985],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868923,0.00021158866,0.000058811776,0.00016028802,0.00043282018,0.00044726176],"domain_scores_gemma":[0.99525887,0.00018784194,0.00023198659,0.00022495376,0.0020516585,0.0020446219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014912601,0.00041346427,0.00033695632,0.0012894493,0.0027649808,0.0017044222,0.0014317483,0.0013876336,0.27515283],"category_scores_gemma":[0.0051609008,0.0002085951,0.0003449974,0.0014038145,0.0005502166,0.00091728027,0.0032281731,0.0020449765,0.06751694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047570516,0.00006980061,0.002448743,0.00009313882,0.0000077500035,0.00007421377,0.00004970896,0.000062149535,0.00013534595,0.0040744985,0.90506095,0.08787614],"study_design_scores_gemma":[0.00002535165,0.000030051788,0.0035811395,0.00007334834,0.0000041126937,0.000118473814,0.00005543412,0.00003318562,0.000048352664,0.0005390918,0.99548763,0.0000038028222],"about_ca_topic_score_codex":0.046329577,"about_ca_topic_score_gemma":0.09548996,"teacher_disagreement_score":0.27515283,"about_ca_system_score_codex":0.0072080404,"about_ca_system_score_gemma":0.03345123,"threshold_uncertainty_score":0.9204779},"labels":[],"label_agreement":null},{"id":"W2067320607","doi":"10.1016/s1658-3876(08)50065-3","title":"Cyclin D1 positive plasma cell myeloma","year":2008,"lang":"en","type":"letter","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Hamilton General Hospital; University of Alberta Hospital; Alberta Hospital Edmonton; University Health Network","funders":"","keywords":"Cyclin D1; Multiple myeloma; Plasma Cell Myeloma; Cancer research; Plasma cell; Cell biology; Chemistry; Medicine; Internal medicine; Biology; Cell cycle; Cancer","score_opus":0.033013270098028825,"score_gpt":0.29931132990877485,"score_spread":0.266298059810746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067320607","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010312501,0.003654302,0.00047225578,0.9331994,0.018239757,0.000056106634,0.00011108362,0.000070065376,0.033884473],"genre_scores_gemma":[0.12464343,0.005401869,0.001717309,0.759634,0.053218376,0.00011698209,0.00013800181,0.00007684298,0.055053182],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9993912,0.00016829032,0.000053886575,0.0000837367,0.00016098932,0.0001419744],"domain_scores_gemma":[0.99843603,0.00097508717,0.000090523376,0.00006876982,0.00016919413,0.00026023743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081876677,0.0005634578,0.0010548754,0.0005990723,0.00271315,0.0015635078,0.001155248,0.023091782,0.005899765],"category_scores_gemma":[0.0055457707,0.00049976987,0.0007139606,0.00054659887,0.0014114019,0.0017497637,0.0007298305,0.014185343,0.0022029392],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028843494,0.0001362595,0.0040361173,0.00015608706,0.000059009733,0.22398281,0.00037163895,0.00040037074,0.0012710664,0.009845387,0.73096365,0.028489202],"study_design_scores_gemma":[0.000524854,0.00031235014,0.0074580717,0.00035279998,0.00017965502,0.30038688,0.00090465375,0.0038182847,0.0016721204,0.020956423,0.66335845,0.00007550948],"about_ca_topic_score_codex":0.0027882631,"about_ca_topic_score_gemma":0.00844873,"teacher_disagreement_score":0.023091782,"about_ca_system_score_codex":0.0035537144,"about_ca_system_score_gemma":0.0014634278,"threshold_uncertainty_score":0.025784135},"labels":[],"label_agreement":null},{"id":"W2106300172","doi":"10.1016/s1658-3876(08)50042-2","title":"Why implement universal leukoreduction?","year":2008,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Leukoreduction; Computer science; Biology","score_opus":0.029085284061874633,"score_gpt":0.3120599392429594,"score_spread":0.2829746551810848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106300172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036421252,0.9891104,0.0006243954,0.007204225,0.000982973,0.000018427612,0.000022162392,0.00002765363,0.001645627],"genre_scores_gemma":[0.0037342082,0.9870004,0.0015373869,0.0057180943,0.00054884644,0.000041448522,0.000045456138,0.0000070711053,0.0013671467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999173,0.00024329814,0.000121540594,0.00014690516,0.00023258707,0.00008261611],"domain_scores_gemma":[0.99838805,0.0007912041,0.00025120538,0.00005707379,0.00042263538,0.00008983679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00307457,0.0006623833,0.0014150565,0.00071570737,0.00023898766,0.001139129,0.001507277,0.0028708007,0.002402852],"category_scores_gemma":[0.0038204018,0.0002833585,0.0005661929,0.001051109,0.0011855825,0.002778263,0.00051881577,0.0031287544,0.0017165304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009701964,0.00008040503,0.0003639019,0.010573483,0.000055230328,0.00026429954,0.00009753359,0.0004627937,0.0010114004,0.0116254715,0.032385837,0.94298255],"study_design_scores_gemma":[0.00007423286,0.00015183589,0.0010336204,0.0049261097,0.00007629992,0.0010439575,0.0001425901,0.00013261687,0.0009921143,0.005190599,0.9862134,0.000022621227],"about_ca_topic_score_codex":0.002180686,"about_ca_topic_score_gemma":0.0021797898,"teacher_disagreement_score":0.00307457,"about_ca_system_score_codex":0.0013829574,"about_ca_system_score_gemma":0.0030570754,"threshold_uncertainty_score":0.016260087},"labels":[],"label_agreement":null},{"id":"W2126600663","doi":"10.1016/s1658-3876(09)50036-2","title":"Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer","year":2009,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vinorelbine; Carboplatin; Chemotherapy; Internal medicine; Cisplatin; Oncology; Febrile neutropenia; Neutropenia; Lung cancer; Surgery","score_opus":0.017052164314345166,"score_gpt":0.29504648141162515,"score_spread":0.27799431709728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126600663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990264,0.0005752879,0.00009199828,0.000055516222,0.0000054070597,0.000009531679,0.000033225137,0.000005300081,0.00019749015],"genre_scores_gemma":[0.9993843,0.00017465226,0.00016463456,0.000038328082,0.000018922548,0.0000087455555,0.000115193616,0.0000020976283,0.00009303422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991347,0.00031544984,0.00013824963,0.00007681524,0.00024452072,0.00009027013],"domain_scores_gemma":[0.9955331,0.0011774689,0.00266725,0.00013043247,0.00018680774,0.00030485945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015623128,0.00011276716,0.00036401371,0.00036838395,0.00021729564,0.00035927293,0.00026289496,0.0003132283,0.0004612465],"category_scores_gemma":[0.006995407,0.00012324077,0.0002783877,0.00057679997,0.00018874471,0.00031229708,0.00021384371,0.00035051059,0.000080722864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014071906,0.0003058061,0.96073055,0.000057570946,0.0000815593,0.000635265,0.000102891594,0.0006760327,0.0019665319,0.000026649175,0.0002004734,0.03380956],"study_design_scores_gemma":[0.00013269193,0.004256217,0.98813325,0.000025309053,0.00006645276,0.0036666237,0.000064845444,0.001302865,0.0012510248,0.00005138839,0.0010418292,0.0000076101796],"about_ca_topic_score_codex":0.0007269432,"about_ca_topic_score_gemma":0.0015588795,"teacher_disagreement_score":0.0015623128,"about_ca_system_score_codex":0.0005573539,"about_ca_system_score_gemma":0.0005136575,"threshold_uncertainty_score":0.008262396},"labels":[],"label_agreement":null},{"id":"W2604827614","doi":"10.1016/j.hemonc.2017.02.002","title":"Hydroxyurea for nontransfusion-dependent β-thalassemia","year":2017,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Meta-analysis; Thalassemia; Medicine; Computer science; Internal medicine","score_opus":0.07452914237322243,"score_gpt":0.3737980496350577,"score_spread":0.29926890726183525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604827614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003230058,0.99578565,0.00008778545,0.00020059633,0.00011377401,0.000057598947,0.00016829516,0.0000072186963,0.00034900545],"genre_scores_gemma":[0.15915644,0.8362267,0.0014204143,0.0012168179,0.00053354073,0.00030014585,0.00054006296,0.00001021168,0.0005956611],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981565,0.0008832138,0.00049298245,0.00013145767,0.00029069523,0.000045219527],"domain_scores_gemma":[0.99375063,0.0038151827,0.0019845008,0.000101663565,0.00025609625,0.0000918614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003054404,0.00049647514,0.0021964607,0.0017193804,0.00020661544,0.0008979796,0.0005406433,0.000722564,0.0044692964],"category_scores_gemma":[0.0069502727,0.00021319691,0.0045379726,0.0017554021,0.00024662004,0.00049309403,0.0003291621,0.00076518726,0.00016546871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014394271,0.00021604753,0.010418197,0.49317598,0.07450196,0.0002923792,0.00012087115,0.00064951816,0.0010719456,0.0011162002,0.0102219535,0.3938207],"study_design_scores_gemma":[0.029634401,0.00850019,0.07573519,0.30359036,0.44515812,0.0026730108,0.00029952652,0.0017789135,0.0034467601,0.0034396113,0.12560056,0.00014327731],"about_ca_topic_score_codex":0.0016233905,"about_ca_topic_score_gemma":0.0031846866,"teacher_disagreement_score":0.0044692964,"about_ca_system_score_codex":0.00080830423,"about_ca_system_score_gemma":0.0011274839,"threshold_uncertainty_score":0.016153455},"labels":[],"label_agreement":null},{"id":"W2731774606","doi":"10.1016/j.hemonc.2017.05.016","title":"Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies","year":2017,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Context (archaeology); Transplantation; Medicine; Hematopoietic stem cell transplantation; Health care; Mandate; Accreditation; Hematopoietic stem cell; Hematopoietic cell; Intensive care medicine; Stem cell; Haematopoiesis; Internal medicine; Economic growth; Political science; Biology; Economics","score_opus":0.08610687944668716,"score_gpt":0.3720520217004427,"score_spread":0.28594514225375556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731774606","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87648296,0.006974189,0.0036937024,0.029742563,0.00082585897,0.00060762203,0.00044511486,0.00004489094,0.08118314],"genre_scores_gemma":[0.975582,0.0059629297,0.0043833447,0.007849419,0.00022296922,0.00034738384,0.00030395674,0.000015154794,0.0053329184],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994172,0.00026906733,0.00002991479,0.000032791708,0.000050242244,0.00020076038],"domain_scores_gemma":[0.9987903,0.00014890675,0.00021435495,0.000030381942,0.00012871377,0.00068739353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012900033,0.00012528016,0.00010134773,0.00028850962,0.0012646501,0.0011411286,0.00042525862,0.0005653732,0.0053224447],"category_scores_gemma":[0.0018276054,0.000095123745,0.0001646831,0.00029919302,0.0006726316,0.00093113544,0.0023456416,0.0007992979,0.00028717643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003913725,0.0015379473,0.6270531,0.0010088081,0.0000761419,0.008708932,0.0064714383,0.0011214679,0.0028737998,0.048772547,0.027588733,0.2743957],"study_design_scores_gemma":[0.00019224563,0.00115628,0.63229907,0.0031085275,0.00013500922,0.00738856,0.053390842,0.001773229,0.0016991062,0.010634884,0.28814358,0.0000786382],"about_ca_topic_score_codex":0.006761359,"about_ca_topic_score_gemma":0.014667934,"teacher_disagreement_score":0.006761359,"about_ca_system_score_codex":0.0010134557,"about_ca_system_score_gemma":0.0066051665,"threshold_uncertainty_score":0.017805398},"labels":[],"label_agreement":null},{"id":"W2892785587","doi":"10.1016/j.hemonc.2018.09.001","title":"Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation","year":2018,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Hematopoietic cell; Hematopoietic stem cell transplantation; Chemotherapy; Medicine; Erythema; Transplantation; Broad spectrum; Haematopoiesis; Pathology; Immunology; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.020139170864182276,"score_gpt":0.2911539118828633,"score_spread":0.27101474101868106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892785587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987527,0.00016782904,0.00008461078,0.000014566846,0.000002453773,0.000014393801,0.00006554853,0.0000030431472,0.00089488586],"genre_scores_gemma":[0.9997465,0.000057814705,0.000061007748,0.000013799413,0.0000065537174,0.000004753398,0.000053259322,8.252073e-7,0.000055444616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997392,0.000052035914,0.000039522405,0.000038322833,0.00005936785,0.000071473274],"domain_scores_gemma":[0.9992487,0.00020022255,0.00027929715,0.00003237415,0.000061798084,0.00017747637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035890526,0.0002381506,0.00022457584,0.0009138127,0.00052479916,0.00035389696,0.00016185943,0.00024536386,0.0025986752],"category_scores_gemma":[0.0016522525,0.00014354757,0.0001787191,0.00060098246,0.0003057139,0.0002743681,0.00038677955,0.0001913512,0.00023329083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020151453,0.0000475322,0.9853769,0.000012499233,0.000015108329,0.010573395,0.000099168356,0.00008276018,0.001195965,0.000029654904,0.00011059401,0.0022550863],"study_design_scores_gemma":[0.000023244978,0.00028742052,0.92089427,0.000015286414,0.00002800603,0.07728705,0.00033718735,0.00023032575,0.00048022048,0.00006706423,0.00034429992,0.000005712682],"about_ca_topic_score_codex":0.0005061144,"about_ca_topic_score_gemma":0.00075020065,"teacher_disagreement_score":0.0025986752,"about_ca_system_score_codex":0.00017867242,"about_ca_system_score_gemma":0.000174873,"threshold_uncertainty_score":0.008693457},"labels":[],"label_agreement":null},{"id":"W2915941540","doi":"10.1016/j.hemonc.2019.02.001","title":"Prediction of Oncotype Dx recurrence score using clinical parameters","year":2019,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada); Sault Area Hospital; NOSM University","funders":"","keywords":"Progesterone receptor; Simple (philosophy); Oncology; Internal medicine; Medicine; Statistics; Mathematics; Computer science; Gynecology; Breast cancer; Cancer; Estrogen receptor","score_opus":0.07774010668270737,"score_gpt":0.3288963078730097,"score_spread":0.25115620119030235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915941540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944641,0.00074099324,0.0028921692,0.00010049713,0.00002832352,0.000038263657,0.00046162418,0.000044760778,0.0012292938],"genre_scores_gemma":[0.99823844,0.00011155487,0.001017182,0.000011392995,0.000018136807,0.000013940071,0.0003643318,0.000002509111,0.00022264861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996877,0.00009810972,0.000045044668,0.000053066477,0.00008880778,0.000027394231],"domain_scores_gemma":[0.99878544,0.0004658357,0.00041840138,0.000054213288,0.00016856036,0.00010748828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006593846,0.00056123076,0.0003151366,0.0011162078,0.00009853798,0.00042619975,0.00021267292,0.0002665864,0.001493379],"category_scores_gemma":[0.002706067,0.000067659574,0.00027014746,0.00049360754,0.00019488206,0.00021971903,0.0003702117,0.00030221985,0.00035459976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027734326,0.00003111975,0.982222,0.000025772428,0.000041809963,0.00011604236,0.000014319121,0.00070467073,0.0010422819,0.000034875746,0.0002820046,0.015207845],"study_design_scores_gemma":[0.000046804413,0.000558175,0.98185515,0.000024900773,0.00011409317,0.0016125025,0.0000647015,0.0112904925,0.0030953418,0.00017144377,0.0011545266,0.000011893793],"about_ca_topic_score_codex":0.0005138514,"about_ca_topic_score_gemma":0.0006035782,"teacher_disagreement_score":0.001493379,"about_ca_system_score_codex":0.00013877382,"about_ca_system_score_gemma":0.00020346849,"threshold_uncertainty_score":0.004995823},"labels":[],"label_agreement":null},{"id":"W3017597775","doi":"10.1016/j.hemonc.2020.04.001","title":"Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation","year":2020,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; Stem Cell Network; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Stemcell Technologies; University of British Columbia","funders":"Canadian Blood Services; University of Ottawa","keywords":"Club; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Haematopoiesis; Hematopoietic cell; Process (computing); Immunology; Biology; Medicine; Cell biology; Internal medicine; Computer science","score_opus":0.05901093002946059,"score_gpt":0.3038925338736823,"score_spread":0.24488160384422172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017597775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51076984,0.006678891,0.13157277,0.012112469,0.0020381701,0.17883784,0.0030520607,0.0014659485,0.15347205],"genre_scores_gemma":[0.62335086,0.004422816,0.22138171,0.011033989,0.0009948922,0.1021972,0.002864963,0.00035013942,0.03340333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99134177,0.0049088798,0.0007505921,0.00054006325,0.0014332838,0.0010255625],"domain_scores_gemma":[0.9964122,0.00072954217,0.00053700927,0.0004459117,0.00077949144,0.0010958562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013046074,0.00061626016,0.00044375897,0.0012306056,0.0020351335,0.0017029275,0.0017790468,0.0009793176,0.023717234],"category_scores_gemma":[0.014869745,0.0002758474,0.0004552404,0.0004868103,0.0006479572,0.0009232435,0.0050834073,0.000829153,0.010195095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035219586,0.005131107,0.06970981,0.0026837406,0.00006567115,0.0023395636,0.010785871,0.0009113811,0.017928518,0.0075880196,0.10822483,0.7711095],"study_design_scores_gemma":[0.004567113,0.01593867,0.2303556,0.00802053,0.00029979664,0.010912935,0.019126715,0.0056172945,0.045873173,0.016464977,0.6425586,0.00026473467],"about_ca_topic_score_codex":0.0015867414,"about_ca_topic_score_gemma":0.0040445435,"teacher_disagreement_score":0.023717234,"about_ca_system_score_codex":0.0013797127,"about_ca_system_score_gemma":0.0065437215,"threshold_uncertainty_score":0.07934201},"labels":[],"label_agreement":null},{"id":"W3027330850","doi":"10.1016/j.hemonc.2020.04.008","title":"Chemotherapy readiness in pediatric oncology","year":2020,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Alberta Children's Hospital","funders":"","keywords":"Urine; Dipstick; Urine specific gravity; Chemotherapy; Medicine; Refractometer; Gold standard (test); Urology; Internal medicine; Materials science","score_opus":0.0443745007052626,"score_gpt":0.3267677309960837,"score_spread":0.2823932302908211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027330850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153167,0.0028963063,0.00031820458,0.0006841932,0.000030812327,0.000059963946,0.00031562234,0.000015816055,0.004147381],"genre_scores_gemma":[0.99834955,0.0009477451,0.00023669236,0.000082419094,0.000013148265,0.000024699475,0.00016184947,0.0000029234072,0.00018100542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936,0.0002489356,0.0000666487,0.00004998255,0.0001212061,0.00015331038],"domain_scores_gemma":[0.99751425,0.00057302875,0.0012703709,0.000054502634,0.00023647088,0.00035134802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007291478,0.00018371554,0.00017411464,0.0008261049,0.00044297182,0.0005120619,0.00018302927,0.00018903233,0.0016389966],"category_scores_gemma":[0.0046271435,0.00009050312,0.00022132245,0.0009493776,0.00036951844,0.0004337454,0.00065856404,0.00055958907,0.00012723313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028376986,0.000027600086,0.9840821,0.00003724525,0.0000068477552,0.0003212838,0.00037991063,0.00006827935,0.000108162945,0.00011700547,0.0004737463,0.014349544],"study_design_scores_gemma":[0.0000024558358,0.00013196301,0.99398935,0.00005157928,0.0000126225805,0.0017443656,0.0011904193,0.00011954358,0.0002628917,0.000111856905,0.0023780577,0.0000050042604],"about_ca_topic_score_codex":0.0040442883,"about_ca_topic_score_gemma":0.006836648,"teacher_disagreement_score":0.0040442883,"about_ca_system_score_codex":0.00087600964,"about_ca_system_score_gemma":0.0011640037,"threshold_uncertainty_score":0.008041501},"labels":[],"label_agreement":null},{"id":"W3045929969","doi":"10.1016/j.hemonc.2020.07.005","title":"The Risk and Prognosis of COVID-19 Infection in Cancer Patients","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Meta-analysis; Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Oncology; Virology; Internal medicine; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.10851786277761712,"score_gpt":0.4418998797513932,"score_spread":0.3333820169737761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045929969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04651995,0.95128864,0.00025288537,0.00036012044,0.00014969693,0.000052672996,0.0007702017,0.000006850276,0.0005990345],"genre_scores_gemma":[0.67878276,0.31792536,0.00066481286,0.00068976096,0.00045299908,0.00013641405,0.0011117171,0.0000124009875,0.00022372574],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99637467,0.0014643556,0.0010720467,0.00046990387,0.0004684863,0.00015047546],"domain_scores_gemma":[0.9905867,0.00617002,0.0022565757,0.00028187173,0.00055666745,0.00014825024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043299063,0.000635866,0.0030963644,0.001947973,0.00029812157,0.0012837608,0.0006850287,0.0011190951,0.0012364791],"category_scores_gemma":[0.015285885,0.00048222463,0.00947225,0.0031598117,0.00033363895,0.00080328714,0.00057717034,0.0010336683,0.00009682192],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007999288,0.00013123109,0.42657685,0.18472877,0.30961004,0.00053714844,0.00032666142,0.001186934,0.0006662571,0.00041254197,0.0027605717,0.06506373],"study_design_scores_gemma":[0.001083936,0.0012627918,0.43832156,0.036021363,0.50826013,0.0015559536,0.00043385214,0.0010950712,0.0006561079,0.0011853242,0.009987508,0.00013638451],"about_ca_topic_score_codex":0.0028042162,"about_ca_topic_score_gemma":0.004836648,"teacher_disagreement_score":0.0043299063,"about_ca_system_score_codex":0.00061374524,"about_ca_system_score_gemma":0.0008222504,"threshold_uncertainty_score":0.022898972},"labels":[],"label_agreement":null},{"id":"W3088032068","doi":"10.1016/j.hemonc.2020.08.005","title":"Vitamin D baseline levels at diagnosis of breast cancer","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Baseline (sea); Meta-analysis; Breast cancer; Medicine; Cancer; Oncology; Internal medicine; Political science","score_opus":0.08496568885239694,"score_gpt":0.38945336544232095,"score_spread":0.30448767658992404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088032068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09252351,0.89695704,0.00051635824,0.000446566,0.00022358779,0.00012096008,0.006978789,0.000025984631,0.002207284],"genre_scores_gemma":[0.877286,0.11439396,0.0008652545,0.00048187905,0.0002274439,0.00028867708,0.005531319,0.000014509334,0.00091089116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629265,0.0010208341,0.00096870336,0.00088605453,0.000691814,0.0001399297],"domain_scores_gemma":[0.9906052,0.005072606,0.0028786175,0.00034428775,0.00090269657,0.00019659412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027431925,0.00043778925,0.0028953366,0.002202195,0.00032525003,0.001016548,0.00069976586,0.00083451474,0.004324961],"category_scores_gemma":[0.011460146,0.0005022225,0.0041809077,0.003580323,0.00031191565,0.00066142285,0.00046525252,0.00087729277,0.00026426278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010774085,0.00006715164,0.7433109,0.0989247,0.10533977,0.00033903244,0.00023550566,0.00079999835,0.0009728632,0.00029442617,0.0038794563,0.035062145],"study_design_scores_gemma":[0.0021400002,0.0009625943,0.8094413,0.02258624,0.13789639,0.0023866303,0.00029943214,0.0005580235,0.0009424755,0.0006576874,0.022043249,0.00008602104],"about_ca_topic_score_codex":0.009426128,"about_ca_topic_score_gemma":0.009303137,"teacher_disagreement_score":0.009426128,"about_ca_system_score_codex":0.0013052176,"about_ca_system_score_gemma":0.0009553755,"threshold_uncertainty_score":0.018742502},"labels":[],"label_agreement":null},{"id":"W3092483516","doi":"10.1016/j.hemonc.2020.09.001","title":"Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation","year":2020,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Stem cell; Hematopoietic stem cell transplantation; Transplantation; Haematopoiesis; Oncology; Leukemia; Immunology; Internal medicine; Biology; Genetics","score_opus":0.015094147521941147,"score_gpt":0.2650793779736378,"score_spread":0.24998523045169663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092483516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924856,0.00031135624,0.00004588875,0.00003739053,0.0000057335265,0.0000038480116,0.000107096814,0.0000020221921,0.00023808461],"genre_scores_gemma":[0.9995202,0.00010386179,0.000027643662,0.000023416433,0.000019636214,0.000003144012,0.00025808768,7.2760594e-7,0.000043306034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968493,0.00006263413,0.00004800663,0.00005061452,0.00007860666,0.00007514289],"domain_scores_gemma":[0.9981104,0.00025152025,0.0012113793,0.000044757006,0.00009106073,0.00029091473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058285,0.00022548922,0.00031115735,0.00047526747,0.00027394984,0.0005057568,0.00021767037,0.0003012961,0.0011852911],"category_scores_gemma":[0.0020936113,0.000105178435,0.0002943043,0.00054862193,0.00030522147,0.0004202538,0.00044625707,0.00045215702,0.00016592641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014982877,0.000017048507,0.99807405,0.000006282463,0.00002415735,0.0002485612,0.00002442822,0.000058087913,0.00012941707,0.000012667986,0.00006790913,0.0011875557],"study_design_scores_gemma":[0.000014665904,0.00023194433,0.996849,0.000012585622,0.00004269998,0.002125748,0.00013386308,0.00023958311,0.000103566155,0.000045035486,0.0001972865,0.0000041078993],"about_ca_topic_score_codex":0.00060614356,"about_ca_topic_score_gemma":0.0009489549,"teacher_disagreement_score":0.0011852911,"about_ca_system_score_codex":0.00022067198,"about_ca_system_score_gemma":0.00028113794,"threshold_uncertainty_score":0.003965199},"labels":[],"label_agreement":null},{"id":"W3131252046","doi":"10.1016/j.hemonc.2021.01.001","title":"Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients","year":2021,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"CSL Behring","keywords":"Hematopoietic cell; Antibody; Hematopoietic stem cell transplantation; Immunology; Medicine; Haematopoiesis; Transplantation; Biology; Stem cell; Internal medicine; Genetics","score_opus":0.014850172002607326,"score_gpt":0.2536545451135334,"score_spread":0.2388043731109261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131252046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930024,0.00031688198,0.00003717351,0.000032218828,0.0000032596704,0.000017506503,0.00004534255,0.0000015459699,0.00024588252],"genre_scores_gemma":[0.99958366,0.00014213017,0.00006940095,0.0000682557,0.000010800774,0.000013021487,0.00007987484,4.630818e-7,0.00003233242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997186,0.00011261402,0.000032177955,0.000038738584,0.00005839297,0.000039440936],"domain_scores_gemma":[0.99927145,0.00013582897,0.00041384608,0.000018811023,0.000032270487,0.00012785287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053493044,0.0001723029,0.00028600154,0.00022501372,0.00026838356,0.00042021333,0.00012269552,0.00018223173,0.0010606768],"category_scores_gemma":[0.00094075786,0.000061017574,0.00023234209,0.00042898965,0.00017826365,0.00016356807,0.00020224799,0.00026191748,0.00011461544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023893043,0.00046193253,0.98143595,0.000066425186,0.00006429131,0.00040896962,0.00009473337,0.00012772581,0.0017111737,0.00003746007,0.00022291121,0.012979196],"study_design_scores_gemma":[0.0006700009,0.012090338,0.97985053,0.000045728953,0.00014138792,0.0035769644,0.00040246145,0.00087946665,0.0010876412,0.000093793664,0.0011538127,0.000007856445],"about_ca_topic_score_codex":0.000482332,"about_ca_topic_score_gemma":0.0004997617,"teacher_disagreement_score":0.0010606768,"about_ca_system_score_codex":0.0002501777,"about_ca_system_score_gemma":0.00033451864,"threshold_uncertainty_score":0.0035482645},"labels":[],"label_agreement":null},{"id":"W3138897860","doi":"10.1016/j.hemonc.2021.03.003","title":"Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Myeloid leukemia; Hematopoietic stem cell transplantation; Hazard ratio; Transplantation; Oncology; Incidence (geometry); Proportional hazards model; Gastroenterology; Confidence interval","score_opus":0.01554791111714027,"score_gpt":0.27554538541022144,"score_spread":0.2599974742930812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138897860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989349,0.00039597767,0.00009795276,0.000052244755,0.000005996489,0.0000044933013,0.00011112657,0.0000037924522,0.00039346702],"genre_scores_gemma":[0.99952817,0.00009235407,0.000033689077,0.000011529863,0.000020069143,0.000002519885,0.00025815202,0.0000015406187,0.000052122712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996599,0.000082958046,0.000058078098,0.000047846188,0.00008905856,0.00006219715],"domain_scores_gemma":[0.99660695,0.00059302273,0.0019991857,0.000071016795,0.00022906385,0.0005007974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000643773,0.0001934447,0.0001805568,0.00033819667,0.00020681611,0.00043471588,0.00024595365,0.00023444452,0.0014380285],"category_scores_gemma":[0.0028874497,0.00005832057,0.00020201824,0.00042915097,0.00024046305,0.00027548047,0.00031252316,0.0004266715,0.00022727641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008616238,0.00001504681,0.9980344,0.0000053219933,0.000015752268,0.00012429814,0.000015155398,0.00008700884,0.00015717986,0.000007647565,0.00006375338,0.001388233],"study_design_scores_gemma":[0.000009768837,0.00017307737,0.99652606,0.000011008041,0.000041673353,0.0021888013,0.00007017589,0.00034844855,0.00026692307,0.000045265515,0.0003154723,0.0000032682676],"about_ca_topic_score_codex":0.00035470456,"about_ca_topic_score_gemma":0.00045872267,"teacher_disagreement_score":0.0014380285,"about_ca_system_score_codex":0.00020146428,"about_ca_system_score_gemma":0.00031484774,"threshold_uncertainty_score":0.004810691},"labels":[],"label_agreement":null},{"id":"W3215272198","doi":"10.1016/j.hemonc.2021.09.008","title":"Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center","year":2021,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Hematopoietic stem cell transplantation; Chronic lymphocytic leukemia; Transplantation; Stem cell; Single Center; Total body irradiation; Surgery; Leukemia; Gastroenterology; Oncology; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.011302720513925961,"score_gpt":0.2569414265498929,"score_spread":0.2456387060359669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215272198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991229,0.00018348484,0.000023021235,0.00006091413,0.0000032152052,0.0000049700006,0.00039392617,0.0000025955933,0.00020492457],"genre_scores_gemma":[0.99918824,0.00007437234,0.000017455863,0.000037918064,0.00000808963,0.0000037497557,0.00060992147,0.0000012936362,0.000058961767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996381,0.00007318153,0.000048049584,0.00007229184,0.00006617507,0.000102314065],"domain_scores_gemma":[0.99861395,0.00017886487,0.00065034506,0.000058296082,0.0001664738,0.00033214636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052044087,0.00023216075,0.0003064116,0.0005369339,0.0005197496,0.0006987226,0.00031897664,0.00035655126,0.0016100976],"category_scores_gemma":[0.0013237599,0.0001366135,0.00029465443,0.00094099494,0.00027752222,0.00040873748,0.0007325341,0.00037815847,0.00022484345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000973563,0.00002347256,0.998381,0.000008739417,0.00002445352,0.0001003639,0.00008994073,0.0000430877,0.00009017976,0.0000070466376,0.00013942775,0.000994876],"study_design_scores_gemma":[0.000019829682,0.000121708545,0.9986014,0.000014268666,0.000029932104,0.00041721525,0.00037409976,0.000112454596,0.00009858777,0.000014680425,0.00019128952,0.0000045836055],"about_ca_topic_score_codex":0.0081367185,"about_ca_topic_score_gemma":0.011869764,"teacher_disagreement_score":0.0081367185,"about_ca_system_score_codex":0.00088511215,"about_ca_system_score_gemma":0.0007146935,"threshold_uncertainty_score":0.016178727},"labels":[],"label_agreement":null},{"id":"W4362643962","doi":"10.56875/2589-0646.1044","title":"Managing Sickle Cell Disease in Patients for Whom Blood Transfusion Is Not an Option","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Blood transfusion; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.038336307568596774,"score_gpt":0.31851515952181836,"score_spread":0.28017885195322156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362643962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018525156,0.99747974,0.000117886084,0.0004902867,0.00017838489,0.0000073969222,0.000023698905,0.000006732001,0.0015106807],"genre_scores_gemma":[0.0010587737,0.99777883,0.00025659226,0.00035735796,0.00013344688,0.00000771901,0.000047159738,0.0000014195514,0.0003587578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998018,0.000045888683,0.0000382098,0.000025960013,0.00007120757,0.000016922897],"domain_scores_gemma":[0.99962664,0.00021931599,0.00005468174,0.000007266949,0.00007221591,0.000019799825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003693357,0.0004444687,0.0006797953,0.0012647099,0.00025037574,0.0006940385,0.0005389572,0.00079242623,0.0034573034],"category_scores_gemma":[0.0013426802,0.00010510664,0.00051079976,0.0008220275,0.00022453001,0.00075216853,0.00045461074,0.0010974392,0.0009990028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048868344,0.00005116501,0.0002564274,0.02263081,0.000093272254,0.00022971627,0.000091973256,0.00018407365,0.0005202775,0.0016933202,0.031653885,0.94254625],"study_design_scores_gemma":[0.000029804147,0.00008672737,0.0012174747,0.02102587,0.00028447577,0.003753317,0.00012964691,0.000102022714,0.00031326315,0.0019435526,0.9710978,0.00001594396],"about_ca_topic_score_codex":0.00084670406,"about_ca_topic_score_gemma":0.0021844483,"teacher_disagreement_score":0.0034573034,"about_ca_system_score_codex":0.0003506446,"about_ca_system_score_gemma":0.00091597025,"threshold_uncertainty_score":0.011565864},"labels":[],"label_agreement":null},{"id":"W4362644007","doi":"10.56875/2589-0646.1027","title":"Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Renal cell carcinoma; Medicine; Clinical trial; Oncology; Internal medicine; Cancer research","score_opus":0.18934356529509228,"score_gpt":0.4355783261040979,"score_spread":0.24623476080900564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362644007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012487076,0.9974112,0.0001437908,0.0001775268,0.0000859163,0.0002960551,0.00038259602,0.000009838254,0.00024438914],"genre_scores_gemma":[0.026246043,0.97132605,0.0006342913,0.00064044626,0.00010650077,0.0005518486,0.00035836778,0.000009613604,0.00012681169],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.992927,0.0023232673,0.0030391936,0.0005648063,0.0009836484,0.00016210499],"domain_scores_gemma":[0.97687316,0.015363277,0.0051284037,0.00033779084,0.0020188813,0.00027835846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00933102,0.0014763317,0.011839714,0.005307772,0.00050115085,0.0023467299,0.0020076109,0.0014955101,0.004059598],"category_scores_gemma":[0.029949607,0.00090042007,0.0095196115,0.006604256,0.00082618557,0.0017957652,0.00113209,0.0011908222,0.00033039108],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008247594,0.000015831038,0.00050573616,0.94410247,0.029778333,0.000047994577,0.000077225464,0.00009509191,0.00018441591,0.00010575269,0.00084130105,0.02342111],"study_design_scores_gemma":[0.0021109586,0.0006038433,0.004746116,0.60722893,0.36907068,0.0003010963,0.00019155076,0.0001517624,0.00035509732,0.00039200272,0.014793112,0.00005474091],"about_ca_topic_score_codex":0.004068607,"about_ca_topic_score_gemma":0.011215069,"teacher_disagreement_score":0.011839714,"about_ca_system_score_codex":0.0026330224,"about_ca_system_score_gemma":0.00545833,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4385704450","doi":"10.56875/2589-0646.1111","title":"A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes","year":2023,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Ibrutinib; Imatinib; Medicine; Oncology; Real world data; Internal medicine; Intensive care medicine; Myelofibrosis; Leukemia; Data science; Computer science; Bone marrow; Chronic lymphocytic leukemia","score_opus":0.0958834157604409,"score_gpt":0.36096196308239636,"score_spread":0.26507854732195546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385704450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987864,0.00043290274,0.00018847788,0.00008579551,0.000009382401,0.00002938387,0.000056132292,0.0000059658137,0.000405643],"genre_scores_gemma":[0.99878854,0.00030900282,0.0003328434,0.00015221225,0.000043809538,0.000023342769,0.00015390605,0.000004592713,0.00019183275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926513,0.0002550046,0.00008905922,0.00013574964,0.00008530716,0.00016974061],"domain_scores_gemma":[0.99853885,0.00022547612,0.00037956372,0.00008992253,0.00010242676,0.0006638283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001347345,0.00040455224,0.0003674126,0.00035666823,0.00097173854,0.0008148696,0.00039079104,0.00061941554,0.0016310286],"category_scores_gemma":[0.0020382458,0.00023435382,0.00044673547,0.00050548447,0.0005048172,0.00056580175,0.0009318002,0.000753196,0.0004139474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037644363,0.0078118155,0.8919728,0.00013381006,0.00029023841,0.016143737,0.002811441,0.0009911516,0.0033906286,0.00016163617,0.0019867138,0.07054161],"study_design_scores_gemma":[0.0020244697,0.032838292,0.8829287,0.00013308272,0.00040357836,0.063261636,0.0044442443,0.0024198035,0.0027296958,0.00023422168,0.008463061,0.000119205986],"about_ca_topic_score_codex":0.0011144212,"about_ca_topic_score_gemma":0.0015911342,"teacher_disagreement_score":0.0016310286,"about_ca_system_score_codex":0.00095197867,"about_ca_system_score_gemma":0.00064152275,"threshold_uncertainty_score":0.0071255565},"labels":[],"label_agreement":null},{"id":"W4403478805","doi":"10.4103/hemoncstem.hemoncstem-d-24-00008","title":"A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome","year":2024,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Aplastic anemia; Medicine; Myelodysplastic syndromes; Bone marrow failure; Flow cytometry; Bone marrow; Anemia; Stem cell; Disease; Pathology; Immunology; Internal medicine; Biology; Haematopoiesis","score_opus":0.024691902540688603,"score_gpt":0.26686379861492804,"score_spread":0.24217189607423945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403478805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9403842,0.0044797375,0.05057039,0.00014933331,0.00013993026,0.0004444587,0.0009793701,0.00021228736,0.0026402122],"genre_scores_gemma":[0.9301344,0.0015196092,0.06401692,0.00018016306,0.00010379109,0.0010709778,0.0011412932,0.000016536009,0.0018162711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990282,0.00034741097,0.00009706951,0.00015530786,0.0002995451,0.0000725052],"domain_scores_gemma":[0.9994186,0.00023493155,0.00010872489,0.00004561598,0.00015628681,0.00003572049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010951515,0.0003903621,0.00033426998,0.0030173196,0.00036640282,0.00045066257,0.000402364,0.00064280035,0.0017382924],"category_scores_gemma":[0.0008353159,0.00015304112,0.00020694174,0.0009616631,0.00035343555,0.00041575113,0.00032239285,0.0006170186,0.0002865911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020553877,0.00057152496,0.0705158,0.00032206034,0.000155217,0.00019070438,0.0003945981,0.00063223747,0.8772867,0.0014515463,0.00043166443,0.045992576],"study_design_scores_gemma":[0.0002486719,0.004198508,0.20759147,0.00009053757,0.0002607252,0.004767982,0.00049353525,0.018036075,0.7508644,0.0021314656,0.011239342,0.0000773369],"about_ca_topic_score_codex":0.0002559874,"about_ca_topic_score_gemma":0.0003821518,"teacher_disagreement_score":0.0030173196,"about_ca_system_score_codex":0.0004854746,"about_ca_system_score_gemma":0.00018025628,"threshold_uncertainty_score":0.0058151484},"labels":[],"label_agreement":null}]}